Clinical Trial Update: BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BuqitongluO Granule targeting qi deficiency and blood stasis syndrome in ischemic stroke and related cardiovascular conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetic Peripheral Neuropathy
• Stable Angina
• Stroke

Drugs mentioned

• BuqitongluO Granule

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Stroke, Ischemic, Coronary Artery Disease | Phase 2 | Status: UNKNOWN